Angiogenesis, Metabolism, Endothelial and Platelet Markers in Diabetes and Cardiovascular Disease
British Journal of Biomedical Science · 22.03.2022 · 79
DOI: 10.3389/bjbs.2022.10313 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Biomedical Science, online erschienen am 22.03.2022. Verfasst von A D Blann und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Applied Sciences, Huddersfield University, Huddersfield, United Kingdom. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Cystatins, Diabetes Mellitus. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Diabetes is a leading risk factor for cardiovascular disease (CVD), the pathophysiology of both being linked to metabolic, endothelial, renal, angiogenic and platelet abnormalities. We hypothesised that abnormalities in these systems are more adverse in those whose CVD is compounded by diabetes, compared to those with diabetes or CVD alone. Materials and methods: Serum or plasma from 66 patients with diabetes alone, 76 with CVD alone, and 70 with both diabetes and CVD i.e. diabetic cardiovascular disease, was probed for markers of angiogenesis [angiopoietin 1 and 2, vascular endothelial growth factor (VEGF) and endoglin], metabolic [soluble receptor for advanced glycation products (sRAGE), leptin, lipocalin-2, interleukin-8, and cystatin-C], the endothelium (von Willebrand factor, endothelial microparticles and soluble E selectin)], and the platelet (platelet microparticles and soluble P selectin) by ELISA, Luminex or flow cytometry.
Results
VEGF ( p = 0.04), von Willebrand factor ( p = 0.001) and endothelial microparticles ( p = 0.042) were all higher in diabetic cardiovascular disease than in diabetes alone and cardiovascular disease alone. Soluble E selectin was higher in diabetic cardiovascular disease than in diabetes alone ( p = 0.045), whilst cystatin-C ( p = 0.004) and soluble P selectin ( p < 0.001) were higher in diabetes and diabetic cardiovascular disease than in cardiovascular disease alone. There were no differences in angiopoietin 1 or 2, endoglin, sRAGE, leptin, lipocalin-2, or interleukin-8.
Conclusion
Angiopoietin 1 or 2, endoglin, sRAGE, leptin, lipocalin-2, interleukin-8, and cystatin-c cannot differentiate diabetes from cardiovascular disease, or both conditions combined. Our data point to a more adverse endothelial (von Willebrand factor, endothelial microparticles), and angiogenic profile (VEGF) in those with diabetic cardiovascular disease, supporting the view that this group should be targeted more aggressively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Applied Sciences, Huddersfield University, Huddersfield, United Kingdom.
- Department of Biosciences, College of Health and Life Sciences, Aston University, Birmingham, United Kingdom.
Zitieren
APA
Blann, A. D., Brown, J. E., & Heitmar, R. (2022). Angiogenesis, Metabolism, Endothelial and Platelet Markers in Diabetes and Cardiovascular Disease. British Journal of Biomedical Science, 79. https://doi.org/10.3389/bjbs.2022.10313
Vancouver
Blann AD, Brown JE, Heitmar R. Angiogenesis, Metabolism, Endothelial and Platelet Markers in Diabetes and Cardiovascular Disease. British Journal of Biomedical Science. 2022;79. doi:10.3389/bjbs.2022.10313
BibTeX
@article{Blann2022,
author = {Blann, A D and Brown, J E and Heitmar, R},
title = {Angiogenesis, Metabolism, Endothelial and Platelet Markers in Diabetes and Cardiovascular Disease},
journal = {British Journal of Biomedical Science},
year = {2022},
volume = {79},
doi = {10.3389/bjbs.2022.10313}
}
EUVIMED